Recombinant Mouse PDK2 Protein，His

PDK2 (Pyruvate Dehydrogenase Kinase 2) is a critical enzyme involved in the regulation of cellular metabolism, specifically in the control of the pyruvate dehydrogenase complex, which plays a pivotal role in converting pyruvate into acetyl-CoA, linking glycolysis to the tricarboxylic acid (TCA) cycle. The dysregulation of PDK2 and its associated pathways has been implicated in various metabolic disorders, including obesity, diabetes, and cancer. Due to its significant role in altering glucose metabolism and promoting a glycolytic phenotype in tumors, PDK2 has garnered attention as a potential therapeutic target. The recombinant expression of PDK2 has allowed researchers to investigate its structural and functional properties, providing insights into its catalytic mechanisms and regulatory interactions. Furthermore, understanding the modulation of PDK2 activity can uncover novel approaches for interventions in metabolic diseases. The development of specific PDK2 inhibitors might not only enhance metabolic homeostasis but also offer strategies for cancer treatment by disrupting the metabolic flexibility of tumor cells. Thus, the study of recombinant PDK2 not only facilitates a deeper understanding of its biological function but also holds promise for advancing therapeutic avenues in metabolic and oncological research.